Finding an optimal method for imaging lymphatic vessels of the upper limb

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 4, 2004, Pages 555-563

  O'Mahony, Susan ^a   Rose, Sarah L ^a   Chilvers, Alison J ^a   Ballinger, James R ^a   Solanki, Chandra K ^a   Barber, Robert W ^a   Mortimer, Peter S ^b   Purushotham, Arnie D ^a   Peters, A Michael ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

99mTc HIG; 99mTc nanocolloid; Intradermal; Lymph nodes; Lymphoscintigraphy; Subcutaneous

Indexed keywords

HUMAN IMMUNOGLOBULIN; NANOCOLL TC 99M; PROTEIN; TECHNETIUM 99M;

ADULT; ARM; ARTICLE; BREAST CANCER; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE QUALITY; INJECTION SITE; ISOTOPE LABELING; LYMPHADENECTOMY; LYMPHATIC DRAINAGE; LYMPHATIC SYSTEM; LYMPHEDEMA; LYMPHOSCINTIGRAPHY; MACROMOLECULE; MALE; QUALITY CONTROL; SCINTILLATION CAMERA; STATISTICAL SIGNIFICANCE;

EID: 1842664901     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1399-3     Document Type: Article

References (17)

1. Rosse C, Gaddum-Rosse P. Hollinshead's textbook of anatomy, 5th edn. Philadelphia: Lippincott-Raven, 1997.
2. Stanton AWB, Kadoo P, Mortimer PS, Levick JR. Quantification of the initial lymphatic network in normal human forearm skin using fluorescence microlymphography and stereological methods. Microvasc Res 1997; 54:156-163.
3. Leak LV. Electron microscope observations on lymphatic capillaries and the structural components of the connective tissue-lymph interface. Microvasc Res 1970; 2:361-391.
4. Henze E, Schelbert HR, Collins JD, Najafi A, Barrio JR, Bennett LR. Lymphoscintigraphy with Tc-99m-labeled dextran. J Nucl Med 1982; 23:923-929.
5. 99mTc-dextran as a lymphoscintigraphic agent in rabbits. Eur J Nucl Med 1985; 11:80-84.
6. Ohtake E, Matsui K. Lymphoscintigraphy in patients with lymphedema: a new approach using intradermal injections of technetium-99m human serum albumin. Clin Nucl Med 1986; 11:474-478.
7. Nawaz K, Hamad M, Sadek S, Awdeh M, Higazi E, Eklof B, Abdel-Dayem HM. Lymphoscintigraphy in peripheral lymphedema using technetium-labelled human serum albumin: normal and abnormal patterns. Lymphology 1985; 18:181-186.
8. McNeill GC, Witte MH, Witte CL, Williams WH, Hall JN, Patto DD, Pond GD, Woolfenden JM. Whole-body lymphoscintigraphy: preferred method for initial assessment of the peripheral lymphatic system. Radiology 1989; 172:495-502.
9. Svensson W, Glass DM, Bradley D, Peters AM. Measurement of lymphatic function with technetium-99m-labelled polyclonal immunoglobulin. Eur J Nucl Med 1999; 26:504-510.
10. Pain SJ, Nicholas RS, Barber RW, Ballinger JR, Purushotham AD, Mortimer PS, Peters AM. Quantification of lymphatic function for investigation of lymphoedema: depot clearance and rate of appearance of soluble macromolecules in blood. J Nucl Med 2002; 43:318-324.
11. m-HIG as a lymphoscintigraphic agent in rabbits. Nucl Med Commun 1998; 19:665-670.
12. Stanton AWB, Svensson WE, Mellor RH, Peters AM, Levick JR, Mortimer PS. Differences in lymph drainage between swollen and non-swollen regions in arms with breast-cancer-related lymphoedema. Clin Sci 2001; 101:131-140.
13. Levick JR, Mortimer PS. The interpretation of lymphoscintigraphy removal rate constants. Eur J Lymphology 1994; IV:123.
14. Weissleder H, Weissleder R. Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients. Radiology 1988; 167:729-735.
15. Mostbeck A, Kahn P, Partsch H. Quantitative lymphography in lymphoedema. In: Bollinger A, Partsch H, Wolfe JHN, eds. The initial lymphatics. Stuttgart: Thieme; 1984:123-130.
16. Levick JR. An introduction to cardiovascular physiology, 3rd edn. London: Arnold, 2000.
17. Pain SJ, Barber RW, Ballinger JR, Solanki CK, O'Mahony S, Mortimer PS, Purushotham A, Peters AM. Side-to-side symmetry of radioprotein transfer from tissue space to systemic vasculature following subcutaneous injection in normal subjects and patients with breast cancer. Eur J Nucl Med Mol Imaging 2003; 30:657-661.